FDA Adverse Event Injury Summary report: N

CLICKFINE 32GX4MM DONGBAO 7CT

MDR report key: 14501051 · Received May 25, 2022

Report

Report Number
3005170966-2022-00003
Event Type
Injury
Date Received
May 25, 2022
Date of Event
April 20, 2022
Report Date
May 25, 2022
Manufacturer
YPSOMED AG
Product Code
FMI
PMA / PMN Number
K171984
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

IT WAS REPORTED THAT THE INJECTION WITH THE PEN NEEDLE (ARTICLE 700000176, BATCH 211168-01) WAS PAINFUL. THE CUSTOMER DIDN'T RETURN ANY NEEDLES FOR INVESTIGATION. THE INVESTIGATION STARTED WITH A REVIEW FOR ANY INTERNAL DEVIATIONS DURING PRODUCTION, SHOWED NO ABNORMALITIES OR DEVIATIONS FROM THE VALIDATED MANUFACTURING PROCESS. PENETRATION FORCE TESTING WAS PERFORMED WITH 5 SAMPLES RETAINED FROM THE SAME BATCH NUMBER ACCORDING THE INTERNAL PRODUCT SPECIFICATION. THE TESTING SET-UP INCLUDED SCREWING THE NEEDLE ONTO THE HOLDING FIXTURE AND REMOVING THE INNER- AND OUTER PROTECTIVE CAP. THE METHOD INCLUDED PENETRATION IN FOIL UP TO NOMINAL LENGTHS WITH A DEFINED SPEED. NONE OF THE NEEDLES TESTED FROM THE SAME BATCH REACHED BEYOND THE MAXIMUM PENETRATION FORCE OF 1.0N.

Description of Event or Problem · 0

ON (B)(6) 2022, WHILE THE PATIENT WAS PERFORMING AN INSULIN INJECTION, THERE WAS PAIN REPORTED ON THE INJECTION SITE. WHEN THE PATIENT COMPLETED THE INJECTION AGAIN AFTER REPLACING A NEW NEEDLE, THERE WAS STILL PAIN REPORTED AT INJECTION SITE. ON (B)(6)2022, WHILE THE PATIENT WAS PERFORMING AN INSULIN INJECTION, THERE WAS PAIN REPORTED ON THE INJECTION SITE. WHEN THE PATIENT COMPLETED THE INJECTION AGAIN AFTER REPLACING A NEW NEEDLE, THERE WAS STILL PAIN REPORTED AT INJECTION SITE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1815586 CLICKFINE 32GX4MM DONGBAO 7CT PEN NEEDLE FMI YPSOMED AG CLICKFINE 32GX4MM DONGBAO 7CT 211168-01

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other